You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sofosbuvir-velpatasvir drug combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick

Recruiting
  • Hepatitis C
  • OraQuick HCV Antibody test (OraSure Technologies, Inc)
  • +2 more
  • Clayton South, Victoria, Australia
  • +5 more
Aug 16, 2022

Kidney Transplantation, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

Active, not recruiting
  • Kidney Transplantation
  • Hepatitis C
  • Pittsburgh, Pennsylvania
    UPMC
Oct 27, 2021

Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Hepatitis C, Lung Transplant Trial in Pittsburgh (Epclusa)

Active, not recruiting
  • Hepatitis C
  • Lung Transplant
  • Pittsburgh, Pennsylvania
    UPMC
Oct 4, 2021

HCV Trial in Bonn, 's-Hertogenbosch, Nijmegen (sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed)

Withdrawn
  • HCV
  • sofosbuvir/velpatasvir tablet
  • sofosbuvir/velpatasvir crushed
  • Bonn, Germany
  • +2 more
Dec 4, 2020

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Healthy Trial in Changsha (ASC18, ravidasvir and sofosbuvir)

Completed
  • Healthy
  • ASC18
  • ravidasvir and sofosbuvir
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Jan 7, 2021

SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

Recruiting
  • Hepatitis C
  • Epclusa (sofosbuvir and velpatasvir)
  • Guangzhou, Guangdong, China
    Deparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021

Kidney Transplant, Hepatitis C, HCV Trial in Columbus (Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Glecaprevir/Pibrentasvir

Completed
  • Kidney Transplant
  • +2 more
  • Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
  • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]
  • Columbus, Ohio
    Brenda Cuson
Jul 29, 2021

Hepatitis C Virus Infection Trial in France, United States (SOF/VEL, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Tampa, Florida
  • +11 more
Feb 18, 2020

Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Bilaspur, Chhattisgarh, India
    YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021

HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

Not yet recruiting
  • HCV Infection
  • Phnom Penh, Cambodia
    Clinical Trial Unit (Ctu)
Aug 7, 2023

Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

Recruiting
  • Chronic Hepatitis C
  • Chronic Hepatitis B
  • Tenofovir Alafenamide 25 MG
  • Sofosbuvir / Velpatasvir
  • Beijing, Beijing, China
    Peking University First Hospital
Aug 2, 2021

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Hepatitis C Virus Infection Trial in New Zealand, Puerto Rico, United States (VOX, SOF/VEL)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +33 more
Feb 18, 2020

Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,

Completed
Has Results
  • Hepatitis C
  • Transplantation Disease Transmission
  • San Francisco, California
  • +5 more
Feb 10, 2021

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C Virus Infection Trial in New Zealand, Puerto Rico, United States (VOX, SOF/VEL, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +33 more
Feb 18, 2020

Hepatitis C Trial in Karachi (undefined)

Recruiting
  • Hepatitis C
  • Karachi, Sindh, Pakistan
    Clinical trials unit
Feb 10, 2022

Hepatitis C Trial in Boston (Sofosbuvir/Velpatasvir Treatment for 14 days)

Withdrawn
  • Hepatitis C
  • Sofosbuvir/Velpatasvir Treatment for 14 days
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 16, 2020

Hepatitis C Virus Infection Trial in Worldwide (SOF/VEL)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +26 more
Oct 5, 2020

Hepatitis C Trial in Kaohsiung (Epclusa)

Active, not recruiting
  • Hepatitis C
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Jul 8, 2020

Hepatitis C Trial in Worldwide (SOF/VEL for 6 weeks, SOF/VEL for 12 weeks)

Completed
Has Results
  • Hepatitis C
  • SOF/VEL for 6 weeks
  • SOF/VEL for 12 weeks
  • Baltimore, Maryland
  • +24 more
Nov 22, 2021

Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

Completed
Has Results
  • Hepatitis C
  • Cryoglobulinemia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 23, 2020

COVID-19 Trial in Mansoura (Sofosbuvir 400 MG plus Daclatasvir 200mg)

Unknown status
  • COVID-19
  • Sofosbuvir 400 MG plus Daclatasvir 200mg
  • Mansoura, Dakahlyia, Egypt
    Mansoura Faculty of Medicine
Feb 22, 2021